Download the app

DOWNLOAD NOW

watsons online, download the app
  • google-play.png
  • app-store.png
  • app-gallery.png
Our Stores Trending Now
Stores Services
0
MY Bag
Home/Health and RX/Prescription/Diabetes/

Empagliflozin + Linagliptin 25mg/5mg 1 Filmcoated Tablet [PRESCRIPTION REQUIRED]

Empagliflozin + Linagliptin 25mg/5mg 1 Filmcoated Tablet [PRESCRIPTION REQUIRED]
80.00
QUANTITY
Add to Bag
FREE GIFT
Get a free SM Game Park Ticket for a minimum spend of P500 on any product. Valid for Click & Collect and Express Delivery services only
GWP Free SM Game Park Voucher
[1] Free Gift(s) GWP Free SM Game Park Voucher
Terms & Conditions
Product code
50018947
Product Details
About This Shop
Promotion
Payment & Delivery
Product Details
Description

REMINDER: A doctor&rsquo,s prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order ,(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to ,OnlinePharmacy@watsons.com.ph ,with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.

 ,

 ,

Adjunct to diet & exercise to improve glycemic control in adults w/ type 2 DM when treatment w/ both empagliflozin & linagliptin is appropriate.

Place of Origin

Germany

Product Usage

25 mg/5 mg once daily for patients requiring additional glycemic control.

Ingredients

1 film-coated tablet contains 25 mg
empagliflozin and 5 mg linagliptin

Warnings

Limitations of Use
Empagliflozin + Linagliptin (GLYXAMBI) is not
recommended for patients with type 1 diabetes or for the
treatment of diabetic ketoacidosis.
Empagliflozin + Linagliptin (GLYXAMBI) has not been
studied in patients with a history of pancreatitis. May increase risk of hypoglycaemia w/ insulin & sulphonylureas. May add to the diuretic effect of thiazide & loop diuretics & may increase risk of dehydration & hypotension. Empagliflozin: Risk of decreased efficacy w/ UGT enzyme inducers. Linagliptin: Decreased exposure w/ strong P-gp or CYP450 isozyme CYP3A4 inducer eg

Width

1

Height

1

Depth

1

HIDE